A new study by the Kaiser Permanente Institute for Health Policy showed that pharmaceutical spending in the U.S. per capita reached $1,010 in 2012, almost double the per capita cost of Germany, the next highest spender. The Hill reports that price hikes have led the U.S. insurance industry to pick a fight with pharmaceutical companies over the rising cost of specialty drugs.